These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 16144296)
1. Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging. Baumann L; Vujevich J; Halem M; Martin LK; Kerdel F; Lazarus M; Pacheco H; Black L; Bryde J Cutis; 2005 Jul; 76(1):69-73. PubMed ID: 16144296 [TBL] [Abstract][Full Text] [Related]
2. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group. Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343 [TBL] [Abstract][Full Text] [Related]
3. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156 [TBL] [Abstract][Full Text] [Related]
4. Comparable efficacy of adapalene 0.3% gel and tretinoin 0.05% cream as treatment for cutaneous photoaging. Bagatin E; Gonçalves HS; Sato M; Almeida LMC; Miot HA Eur J Dermatol; 2018 Jun; 28(3):343-350. PubMed ID: 30105991 [TBL] [Abstract][Full Text] [Related]
5. N-retinoyl-D-glucosamine, a new retinoic acid agonist, mediates topical retinoid efficacy with no irritation on photoaged skin. Kambayashi H; Odake Y; Takada K; Funasaka Y; Ichihashi M; Kato S Br J Dermatol; 2005 Dec; 153 Suppl 2():30-6. PubMed ID: 16280019 [TBL] [Abstract][Full Text] [Related]
7. Sustained improvement with prolonged topical tretinoin (retinoic acid) for photoaged skin. Ellis CN; Weiss JS; Hamilton TA; Headington JT; Zelickson AS; Voorhees JJ J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):629-37. PubMed ID: 2229490 [TBL] [Abstract][Full Text] [Related]
8. Cosmeceuticals: focus on topical retinoids in photoaging. Serri R; Iorizzo M Clin Dermatol; 2008; 26(6):633-5. PubMed ID: 18940544 [TBL] [Abstract][Full Text] [Related]
9. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist. Sakuta T; Kanayama T Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708 [TBL] [Abstract][Full Text] [Related]
10. The mechanism of action of topical retinoids. Kang S Cutis; 2005 Feb; 75(2 Suppl):10-3; discussion 13. PubMed ID: 15773538 [TBL] [Abstract][Full Text] [Related]
11. Current status of topical tretinoin in the treatment of photoaged skin. Kligman AM Drugs Aging; 1992; 2(1):7-13. PubMed ID: 1554975 [TBL] [Abstract][Full Text] [Related]
12. The use of retinoids in the treatment of photoaging. Singh M; Griffiths CE Dermatol Ther; 2006; 19(5):297-305. PubMed ID: 17014485 [TBL] [Abstract][Full Text] [Related]
13. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams. Griffiths CE; Kang S; Ellis CN; Kim KJ; Finkel LJ; Ortiz-Ferrer LC; White GM; Hamilton TA; Voorhees JJ Arch Dermatol; 1995 Sep; 131(9):1037-44. PubMed ID: 7544967 [TBL] [Abstract][Full Text] [Related]
14. The role of topical retinoids in the treatment of photoaging. Stratigos AJ; Katsambas AD Drugs; 2005; 65(8):1061-72. PubMed ID: 15907143 [TBL] [Abstract][Full Text] [Related]
15. Photoaging and tretinoin. Kang S Dermatol Clin; 1998 Apr; 16(2):357-64. PubMed ID: 9589209 [TBL] [Abstract][Full Text] [Related]
17. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma. Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R; Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307 [TBL] [Abstract][Full Text] [Related]
18. Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel. Sefton J; Kligman AM; Kopper SC; Lue JC; Gibson JR J Am Acad Dermatol; 2000 Oct; 43(4):656-63. PubMed ID: 11004622 [TBL] [Abstract][Full Text] [Related]
19. Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis. Sachs DL; Kang S; Hammerberg C; Helfrich Y; Karimipour D; Orringer J; Johnson T; Hamilton TA; Fisher G; Voorhees JJ Arch Dermatol; 2009 Jun; 145(6):659-66. PubMed ID: 19528421 [TBL] [Abstract][Full Text] [Related]
20. Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study. Hofmann WK; Kell WJ; Fenaux P; Castaigne S; Ganser A; Chomienne C; Burnett R; Kowal C; Hoelzer D; Burnett AK Leukemia; 2000 Sep; 14(9):1583-8. PubMed ID: 10995004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]